[go: up one dir, main page]

WO2008106965A1 - Méthode et appareil de détermination in vivo de la fluorescence émise par la peau - Google Patents

Méthode et appareil de détermination in vivo de la fluorescence émise par la peau Download PDF

Info

Publication number
WO2008106965A1
WO2008106965A1 PCT/DK2007/050028 DK2007050028W WO2008106965A1 WO 2008106965 A1 WO2008106965 A1 WO 2008106965A1 DK 2007050028 W DK2007050028 W DK 2007050028W WO 2008106965 A1 WO2008106965 A1 WO 2008106965A1
Authority
WO
WIPO (PCT)
Prior art keywords
light
fluorescence
illumination area
illumination
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2007/050028
Other languages
English (en)
Inventor
Kåre Christiansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIA MEDICO APS
Original Assignee
DIA MEDICO APS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIA MEDICO APS filed Critical DIA MEDICO APS
Priority to PCT/DK2007/050028 priority Critical patent/WO2008106965A1/fr
Publication of WO2008106965A1 publication Critical patent/WO2008106965A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6844—Monitoring or controlling distance between sensor and tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6886—Monitoring or controlling distance between sensor and tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A61B2560/0462—Apparatus with built-in sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/446—Scalp evaluation or scalp disorder diagnosis, e.g. dandruff

Definitions

  • the present invention relates to a method and an apparatus for de- termination of in vivo fluorescence emitted from a fluorescence generating component in a mammal skin region, where the fluorescence generating component by illumination with light of a wavelength range including a fluorescence excitation wavelength for the component causes emission of fluorescence light of an emission wavelength specific to the fluorescence generating component.
  • the invention specifically relates to the use of the method and apparatus during photodynamic procedures for treatment, investigation or diagnosing of skin conditions.
  • a fluorescence measuring system is used to capture the amount of fluorescence from a skin region by means of a camera and thereby guide the treatment.
  • additional objects of the invention comprise the provision of a fluorescence determination method and apparatus for particular use in monitoring of photodynamic treatment procedures for cosmetic as well as medical applications including investigation and monitoring of pre-exposure stages of such procedures, during which a photosensitizer is applied to a treatment target region and is allowed to incubate therein, and also as a useful tool in diagnosing of benign or malign dermatologic conditions.
  • the invention provides a method for determination of in vivo fluorescence emitted by a fluorescence generating component introduced into a skin region of a patient, comprising the steps of illuminating an illumination area within the skin region with non- focussed pulsed light including a fluorescence excitation wavelength for the fluorescence generating component, measuring light input to detector means arranged to receive light emitted by fluorescence from the illumination area, the detector means having a light-sensitivity range including at least one fluorescence emission wavelength of the fluores- cence generating component, and processing light input measured by the detector means to obtain an averaged quantity of fluorescence from the illumination area and provide an objective quantification thereof with correction for influences from light sources other than the illumination area.
  • the fluorescence generating component which is introduced into the skin region from the outside, may comprise in particular a photosensitizing agent supplied to the skin region by a photosensitizer carrier fluid comprising either the photosensitizing agent as such or a precursor for production of the photosensitizing agent following entry of the precursor in epidermal cells in the skin region.
  • the photosensitizer fluid may comprise as photosensitizer agent a xanthene such as rose bengal.
  • the photosensitizer fluid may comprise as photosensitizer agent a prophyrin.
  • the photosensitizer fluid may comprise ALA or an ALA derivative as precursor for the production of protoporphyrin IX as photosensitizing agent.
  • the precursor may favour- ably be encapsulated in a liposome-based carrier fluid in a relatively low concentration, e.g. between 0.1 % and 2.0 %.
  • the method is suitable, in particular, for use in a photodynamic treatment process for monitoring accumulation of a photosensitizing agent in a skin region or for diagnosing a dermatologic condition implying accumulation of a photosensitizing agent in a skin region.
  • the invention is equally directed to both of these applications.
  • the fluorescence generating component introduced into the skin region may comprise a skin tanning composition, preferably dihydroxyacetone, which is supplied to the skin region.
  • the illumination area is uniformly illuminated.
  • the non-focussed pulsed light may be controlled to provide an illumination area having a size between about 2 and about 20 cm 2 , preferably between 10 and 18 cm 2 .
  • the pulsed light is emitted with a pulse frequency equal to or constituting a whole fraction or multiple of the fre- quency of an operating AC voltage for ambient light sources with respect to a light source used for the non-focussed pulsed light.
  • the correction for influences from light sources other than the irradiation area may be implemented in a simple way by measuring the input to the detector means in light-on as well as light-off periods of the pulsed light.
  • the correction for influences from light sources other than the illu- mination area may be accomplished in said calculation by subtracting the light input measured by the detector means in said light-off periods the light input measured in said light-on periods,
  • an apparatus for determination of in vivo fluorescence from a fluorescence generating component introduced into a skin region comprises a housing including a light source for illumination of an illumination area within the skin region by emission of non-focussed pulsed light including a fluorescence excitation wavelength for the fluorescence generating component, controlled power supply means for supplying and controlling operating power to the light source, first detector means arranged to receive light emitted by fluorescence from the illumination area and having a light-sensitivity range including at least one fluorescence emission wavelength of the fluorescence generating component, and processor means for processing light input measured by the first detector means to obtain an averaged quan- tity of fluorescence from the illumination area and provide an objective quantification thereof with correction for influences from light sources other than the illumination area.
  • the feed-back control means including second detector means arranged to receive light input to the illumination field by emission from the light source.
  • the illumination light source may comprise an arrangement of individual light sources positioned within the housing with substantially equal spacing along the perimeter of a circle for light emission through exit openings in a front surface part of the housing in the form of beams converging towards a common plane to produce substantially uniform illumination of a substantially cir- cular illumination area, which could have a diameter between about 16 and about 50 mm, preferably between 36 and 48 mm.
  • Entry openings for the fluorescence emission from the illumination area may equally be provided by the front surface part of the housing to be positioned with regular spacing between the light exit openings.
  • the housing may in a still further preferred embodiment be adapted for attachment of a digital still or video camera such that a focal plane of the camera is positioned in the illumination area for imaging the fluorescence emitted therefrom.
  • a camera By attachment of a camera to the housing the camera could be connected, possibly via processing means such as a PC, with a display for reproduction of still or live images during use of the apparatus.
  • the housing may be adapted to be handheld.
  • support and spacer means may be connected with the front surface part of the housing for positioning of the illumination light source in a prescribed distance from the illumination area with the housing supported by the support and spacer means resting against the skin region outside the illumination field.
  • figure 1 and 2 are graphic representations of typical excitation and emission wavelengths for examples of preferred fluorescence generating components introduced into a skin region in connection with implementation of the method and apparatus of the invention
  • figure 3 is a schematic block diagram of an embodiment of the apparatus according to the invention
  • figure 4 and 5 are front and rear perspective views, respectively, of a design of the apparatus as a handheld applicator
  • figure 6 is a graphic representation illustrating the feasibility of the invention for diagnosing an example of dermatologic disease.
  • PpIX protoporphyin IX
  • a carrier fluid which could be either a cream-based carrier usually incorporating a relatively high concentration about 20 % of 5-ALA or, more preferably, a lipo- some-based carrier fluid, in which 5-ALA may be encapsulated in a much lower concentration, e.g.
  • a further distinct advantage of using a liposome-based carrier fluid with a relatively low concentration of 5-ALA is that it can easily be applied to the skin by spraying, preferably in the form of a number of repeated spray doses delivered to the skin region as disclosed in copending international patent application "Method for non-theraoeutic and therapeutic photodynamic skin treatment" in the name of Kaare Christiansen et al.
  • Method for non-theraoeutic and therapeutic photodynamic skin treatment in the name of Kaare Christiansen et al.
  • the transformation rate for production of PpIX is further dependent on the rate, at which the precursor such as 5-ALA penetrates through outer skin layers into the epidermal cells.
  • Dependent on the type of carrier fluid used for the supply of the precursor there may be an incubation time of varying length before an accumulation of PpIX sufficient for acti- vation by light exposure has been produced.
  • the incubation time may typically be from 0.2 to 8 hours.
  • an alternatively preferred photosensitizing agent for intro- duction in a skin region as a fluorescence generating component would be a xanthene such as rose bengal, which by illumination with light including an excitation wavelength of 525 nm will generate a distinctive although relative broad fluorescence around an emission wavelength of 594 nm as shown in the graphic representation in figure 2.
  • Rose bengal may be incorporated in any suitable photosensitizer carrier fluid such as a cream or gel, a liquid solution as e.g. ethanol or water or encapsulated in a liposome-based carrier fluid.
  • FIG. 3 shows a schematic block diagram of main components of an embodiment of the apparatus according to the invention.
  • a light source 1 which may be of any structure and design suitable for emission of pulsed light in a wavelength range including excitation wavelengths for one or more fluorescence generating components, with which the method an apparatus of the invention is to be used, is connected with a controlled power supply 2 controlling and supplying operating power to the light source 1.
  • the light source may preferably include an arrangement of LED's configured to provide a substantial uniform illumination of a relatively large illumination area within a skin region subject to fluorescence determination
  • the controlled power supply 2 which acts as a programmable current generator, is controlled to supply a pulsed operating current to the light source 2.
  • the pulse frequency of the operating current for the light source 1 is controlled to be equal to or constitute a whole fraction or multiple of an AC current used for ambient light sources in the vicinity of the apparatus in use.
  • the effective emission spectrum for the illumi- nation light from the light source 1 may be limited by a filter 3 arranged between the light source 1 and the illumination area 4 within a skin region under investigation.
  • the specific function of the filter 3 would be, in particular, to exclude the expected wavelength of the fluorescence emission from the illumination area 4 from the effective emission spectrum from the light source 1, if this expected wavelength is included in the spectral emission range from the light source itself. Limitation of the emission bandwidth from the light source 1 to a desired range could alternatively be provided, however, as an integrated feature of the light source.
  • the light source 1 has thus been configured as an arrangement of six LED's of the type M3L1- HU supplied by Rothner Lasertechnik and having an emission range from 390 to 415 nm.
  • the LED's are positioned along a circle with a diameter of 60 mm and with converging directions of light emission for uniform illumination of a substantially circular illumination area 4 at a distance of 70 mm from the light source 1 and having a diameter of 45 mm and thus an area of about 15.9 cm 2 .
  • the filter 3 was an absorption filter type BG3 with OD>3 in the wavelength range from 520 to 675 nm.
  • a semi-permeable beam splitting mirror 5 arranged in the optical path between the light source 1 and the illumination area 4 the light beam emitted from the light source 1 is split into two unequal fractions, the larger of which is directed to the illumination area 4, whereas the smaller fraction reflected from the mirror 5 is supplied to a light detector 6 forming a feed-back control means for the emission of non-focussed, pulsed light from the light source 1.
  • the spectral bandwidth of the light input to the detector 6 is limited by means of a filter 7 arranged in the optical path between the beam- splitting mirror 5 and the detector 6, to exclude light of wavelengths outside the upper limit of the spectral range of the light impinging on the beam-splitting mirror 5, in particular IR light originating from the light source 1 or ambient light sources.
  • the filter 7 was a reflection filter for IR light beyond a cut-off wavelength of 720 nm.
  • the detector 6 By measuring the intensity of the light input the detector 6 generates a control signal providing a feed-back control for the light emission from the light source 1 to insure a constant light output.
  • phase comparison of the phase of the control signal from the detector 6 with the measuring signal obtained from detection of the light emitted by fluorescence from the illumination area 4 in a manner known per se a phase control of the light emission from the light source 1 may further be obtained.
  • the light emitted by fluorescence from the illumination area 4 is received by a light detector 8, the light input to which is limited by a filter 9 to a relatively narrow wavelength range including the expected fluorescence emission wavelength from the fluorescence generating compo- nent, which has been introduced in the skin region including the illumination area 4.
  • the filter 9 was formed by a combination of a RG610 filter from Schott and an IR reflection filter of the same type as used for the filter 7, thereby limiting the light input to the fluorescence emission detector 8 to a spectral range from 610 to 720 nm.
  • the spectral sensitivity range of the fluorescence emission detector 9 could be from about 580 nm to about 800 nm to cover the emission wavelengths of various fluorescence generating components including e.g. rose Bengal, or the filter 9 may be exchangeable for adaptation to specific fluorescence generating components.
  • the electrical measuring signals obtained from the detector 8 in re- sponse to the intensity of the detected light input emanating from the fluorescence emission from the illumination area 4 is supplied to a microprocessor 10, in which the signals are processed into objectively quantified fluorescence values, which are supplied to a display 11 for visual display.
  • the light source 1 is controlled and operated from the controlled power supply 2 in a square pulse mode, for which as mentioned above the pulse frequency is selected to be equal to or to constitute a whole fraction or multiple of the normal 50 or 60 HZ operating AC current for ambient light sources in the environment, in which the apparatus is used.
  • the pulse frequency could be 300 Hz with a duty cycle of 30 %.
  • the fluorescence detector 8 and the microprocessor 10 may be controlled to measure the intensity of the light input to the detector 8 both in light-on and light-off periods of the pulsed light.
  • the microprocessor 10 is preferably structured, controlled or programmed to calculate quantified output values to be displayed by subtraction of detector signals measured by the detector in the light-off periods from the detector signals measured in the light-on periods.
  • measuring signals supplied from the detector 8 to the microprocessor 10 in the light-on and light-off periods, respectively are sampled into digital values and an average over several samples is calculated before the subtraction of the light-off signals from the light-on signals.
  • the microprocessor 10 is further connected with the controlled power supply 2 and receives input from the feed-back control detector 6 for control of the light emission from the light source 1 via the controlled power supply 2.
  • a preferred design of the apparatus as a handheld applicator adapted for attachment to the optics of a standard digital camera is shown in perspective views from the front and rear sides, respectively.
  • a front surface portion 12 of the applicator housing 13 six exit openings Ll to L6 are located for light emission from six LED's positioned inside the housing 13 in a substantially circular arrangement with substantially equal spacing between them, the exit openings L1-L6 being positioned with substantially uniform separation on a circle surrounding a central opening 14 serving as image entry for a digital camera (not shown) that may be attached to the rear side of the housing 13 shown in figure 5.
  • Equally distributed between the light exit openings Ll to L6 are six entry openings Fl to F6 for input of fluorescence light to fluorescence detector components positioned in the housing 13 behind the front surface portion 12.
  • Spectral limitation filters such as the filters 3 and 9 in figure 3 may be provided for each of the light exit openings L1-L6 and each of the fluorescence entry openings F1-F6, respectively, preferably by being arranged in an exchangeable filter holder (not shown) located in the housing 13 with the filters positioned in alignment with their re- spective exit or entry openings.
  • the individual LED light sources are configured and positioned for emission of light towards the circular illumination area 4 in light beams converging towards the common plane of the skin region, within which the illumination area 4 is located, thereby providing a substantially uniform illumination of the illumination area.
  • the numerical display 11 is positioned in an upper part outside the portion of the rear side that will be covered by the housing of a camera attached to the applicator.
  • the common plane, towards which the light beams from the exit openings Ll to L6 in the front surface portion 12 converge, can conveniently be about 70 mm in front of the front surface portion 12.
  • the applicator is preferably equipped with support and spacer means extend- ing from the front surface portion 12 to the common plane for the converging light beams.
  • such support and spacer means is formed as shown in figure 5 by a funnel-like frustro-conical light screen 15 connected with the front surface portion 12.
  • the illustrated applicator may thus be positioned with the free end of the light screen 15 in contact with the skin region under investigation outside the illumination area 4 and the opposite end of the screen 15 in engagement with a recess or track 16 surrounding the front surface portion 12.
  • figure 6 shows a graphic representation of fluorescence intensity levels measured from target regions of normal skin and a skin region having a high metabolic activity caused by actinic keratosis. The pronounced difference in fluorescence intensity is caused by the ability of a photosensitizing agent introduced into the skin region to accumulate in areas having a high metabolism.
  • the method and apparatus of the invention may find useful application in investigation of skin desquamation and stratum corneum renewal.
  • the outer layer of the skin, the epidermis is composed of a series of overlying layers of cells, all of which are produced in the lower basal layer. During their continuous production the cells are pushed upwards towards the skin surface while undergoing a maturation process, in which the epidermal cells (the keratinocytes) change their metabolism and morphological shape and turn into flat sheets of keratin forming the outermost stratum corneum layer, these cells being bound to each other by lipids and waxes to from a waterproof outer protective sheath for the body.
  • the epidermal cells the keratinocytes
  • the rate of cell production and hence the shedding or desquamation of the outermost cells is important both in connection with skin diseases and for skin health in general. Thus, a too low desquamation rate may result in a leaky protective layer and a too high rate in visible scaled, a dull skin appearance or dandruff.
  • DHA is an ingredient of many commercial skin tanning compositions with temporary effect the use can be considered very safe.
  • the stratum corneum turnover rate and the barrier function may be determined in vivo by objective and quantified assessment.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

On détermine la fluorescence in vivo émise par une région de la peau, dans laquelle un composant générateur de fluorescence a été introduit: en éclairant une zone d'illumination de la peau avec de la lumière pulsée non-focalisée; en mesurant au moyen de détecteurs arrangés pour recevoir la lumière émise par la fluorescence de la zone d'illumination la lumière reçue par les détecteurs dont la plage de sensibilité comporte au moins une longueur d'onde d'émission de fluorescence du générateur de fluorescence; et à traiter la quantité de lumière reçue mesurée par les détecteurs pour obtenir la quantité moyennée de fluorescence de la zone d'illumination et fournir une quantification objective en corrigeant l'influence de sources lumineuses autres que celles provenant de la zone d'illumination. L'appareil de détection de fluorescence peut être conçu avantageusement comme un applicateur à main présentant un logement (13), ainsi qu'un support et un espaceur permettant de le positionner de manière à obtenir un éclairage sensiblement uniforme sur une zone d'illumination relativement étendue de la peau. Le logement (13) de l'applicateur peut par ailleurs être adapté pour permettre de fixer un appareil photo numérique ou une caméra vidéo.
PCT/DK2007/050028 2007-03-06 2007-03-06 Méthode et appareil de détermination in vivo de la fluorescence émise par la peau Ceased WO2008106965A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/DK2007/050028 WO2008106965A1 (fr) 2007-03-06 2007-03-06 Méthode et appareil de détermination in vivo de la fluorescence émise par la peau

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2007/050028 WO2008106965A1 (fr) 2007-03-06 2007-03-06 Méthode et appareil de détermination in vivo de la fluorescence émise par la peau

Publications (1)

Publication Number Publication Date
WO2008106965A1 true WO2008106965A1 (fr) 2008-09-12

Family

ID=38596622

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2007/050028 Ceased WO2008106965A1 (fr) 2007-03-06 2007-03-06 Méthode et appareil de détermination in vivo de la fluorescence émise par la peau

Country Status (1)

Country Link
WO (1) WO2008106965A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2810603A4 (fr) * 2012-01-30 2015-11-04 Ccs Inc Dispositif d'éclairage pour la détection de tumeurs et dispositif d'éclairage pour les examens
GB2620662A (en) * 2022-07-11 2024-01-17 Earswitch Ltd Improvements in or relating to remotely capturing biometric data

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608990A (en) * 1983-09-12 1986-09-02 Elings Virgil B Measuring skin perfusion
WO2002061405A2 (fr) * 2001-01-31 2002-08-08 Pottier Roy H Procédé et dispositif portable de détection de fluorescence
US6748259B1 (en) * 2000-06-15 2004-06-08 Spectros Corporation Optical imaging of induced signals in vivo under ambient light conditions
WO2006099653A1 (fr) * 2005-03-23 2006-09-28 Rofin Australia Pty Ltd Source de lumiere de therapie photodynamique
US7135033B2 (en) * 2002-05-23 2006-11-14 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants and topical substances

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608990A (en) * 1983-09-12 1986-09-02 Elings Virgil B Measuring skin perfusion
US6748259B1 (en) * 2000-06-15 2004-06-08 Spectros Corporation Optical imaging of induced signals in vivo under ambient light conditions
WO2002061405A2 (fr) * 2001-01-31 2002-08-08 Pottier Roy H Procédé et dispositif portable de détection de fluorescence
US7135033B2 (en) * 2002-05-23 2006-11-14 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants and topical substances
WO2006099653A1 (fr) * 2005-03-23 2006-09-28 Rofin Australia Pty Ltd Source de lumiere de therapie photodynamique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KLEINPENNING M M ET AL: "Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study.", September 2006, THE BRITISH JOURNAL OF DERMATOLOGY SEP 2006, VOL. 155, NR. 3, ISSN: 0007-0963, XP002462168 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2810603A4 (fr) * 2012-01-30 2015-11-04 Ccs Inc Dispositif d'éclairage pour la détection de tumeurs et dispositif d'éclairage pour les examens
GB2620662A (en) * 2022-07-11 2024-01-17 Earswitch Ltd Improvements in or relating to remotely capturing biometric data
GB2620662B (en) * 2022-07-11 2025-05-07 Earswitch Ltd Improvements in or relating to remotely capturing biometric data

Similar Documents

Publication Publication Date Title
EP2289413B1 (fr) Système d'imagérie de la peau comprenant une sonde
US6123719A (en) Diagnostic apparatus utilizing radiation interaction with biological tissue
US8496695B2 (en) Apparatus and method for photodynamic diagnosis and therapy of skin diseases and light source system thereof
US4894547A (en) Optical method and apparatus for detecting and measuring aging, photoaging, dermal disease and pigmentation in skin
JP4521587B2 (ja) 照明の均一度を向上させた光学診断装置
Ruiz et al. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin
Hegyi et al. New developments in fluorescence diagnostics
Kulyk et al. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin
US7656522B2 (en) Depth selective pH measurement and UV exposure measurement
Han et al. Analysis of facial sebum distribution using a digital fluorescent imaging system
WO2008106965A1 (fr) Méthode et appareil de détermination in vivo de la fluorescence émise par la peau
EP1161924A1 (fr) Procede de diagnostic de regions de proliferation et dispositif de mise en oeuvre de ce procede
RU2088156C1 (ru) Автоматизированное устройство для диагностики в онкологии
RU2169922C1 (ru) Способ диагностики областей пролиферации и устройство для его осуществления
Yang et al. An in vitro Raman study on compositional correlations of lipids and protein with animal tissue hydration
JP5367267B2 (ja) 生物組織、特には人間の皮膚を観察する方法
Grishanov et al. Estimation of the advanced glycation end products accumulated by sclera using autofluorescence
Davis et al. Instrument for measurement of singlet oxygen for studies of skin under UVA irradiation
Ardigò et al. Non-invasive methods for vitiligo evaluation
Han et al. In vivo fluorescence spectroscopic monitoring of radiotherapy in cancer treatment
Valentine Biophysical aspects of photodynamic therapy
JP2004097430A (ja) 皮脂の遊離不飽和脂肪酸率評価方法
Troyanova et al. Fluorescence and reflectance properties of hemoglobin-pigmented skin disorders
Zhou et al. Developing laser-based therapy monitoring of early caries in pediatric dental settings
RU2169518C1 (ru) Способ световой топической диагностики биообъектов

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07702536

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07702536

Country of ref document: EP

Kind code of ref document: A1